JP4305909B2 - 六環式化合物 - Google Patents

六環式化合物 Download PDF

Info

Publication number
JP4305909B2
JP4305909B2 JP2003547402A JP2003547402A JP4305909B2 JP 4305909 B2 JP4305909 B2 JP 4305909B2 JP 2003547402 A JP2003547402 A JP 2003547402A JP 2003547402 A JP2003547402 A JP 2003547402A JP 4305909 B2 JP4305909 B2 JP 4305909B2
Authority
JP
Japan
Prior art keywords
ethyl
hydroxy
pyrano
pyrido
quinazoline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2003547402A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005511643A5 (https=
JP2005511643A (ja
Inventor
村田　　毅
諭 新妻
信夫 新間
ひとみ 須田
雅雄 塚崎
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of JP2005511643A publication Critical patent/JP2005511643A/ja
Publication of JP2005511643A5 publication Critical patent/JP2005511643A5/ja
Application granted granted Critical
Publication of JP4305909B2 publication Critical patent/JP4305909B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2003547402A 2001-11-30 2002-11-25 六環式化合物 Expired - Fee Related JP4305909B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01128361 2001-11-30
PCT/EP2002/013216 WO2003045952A2 (en) 2001-11-30 2002-11-25 Condensed camptothecins as antitumor agents

Publications (3)

Publication Number Publication Date
JP2005511643A JP2005511643A (ja) 2005-04-28
JP2005511643A5 JP2005511643A5 (https=) 2006-01-05
JP4305909B2 true JP4305909B2 (ja) 2009-07-29

Family

ID=8179394

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003547402A Expired - Fee Related JP4305909B2 (ja) 2001-11-30 2002-11-25 六環式化合物

Country Status (28)

Country Link
US (2) US6825194B2 (https=)
EP (1) EP1480984B9 (https=)
JP (1) JP4305909B2 (https=)
KR (1) KR100895746B1 (https=)
CN (1) CN100338066C (https=)
AT (1) ATE398131T1 (https=)
AU (1) AU2002356720B2 (https=)
BR (1) BR0214615A (https=)
CA (1) CA2468824C (https=)
DE (1) DE60227113D1 (https=)
ES (1) ES2307830T3 (https=)
GT (1) GT200200250A (https=)
HU (1) HUP0500062A3 (https=)
IL (1) IL162058A0 (https=)
MX (1) MXPA04005185A (https=)
MY (1) MY136138A (https=)
NO (1) NO329005B1 (https=)
NZ (1) NZ533568A (https=)
PA (1) PA8558901A1 (https=)
PE (1) PE20030725A1 (https=)
PL (1) PL207510B1 (https=)
RS (1) RS51051B (https=)
RU (1) RU2299212C2 (https=)
TW (1) TWI258481B (https=)
UA (1) UA80409C2 (https=)
UY (1) UY27560A1 (https=)
WO (1) WO2003045952A2 (https=)
ZA (1) ZA200404522B (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006518374A (ja) * 2003-02-21 2006-08-10 中外製薬株式会社 六環式化合物の調製法

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2413731C2 (ru) 2004-04-09 2011-03-10 Чугаи Сейяку Кабусики Кайся Новые растворимые в воде пролекарства
TW200744603A (en) * 2005-08-22 2007-12-16 Chugai Pharmaceutical Co Ltd Novel anticancer concomitant drug
CA2626330A1 (en) * 2005-10-19 2007-04-26 Chugai Seiyaku Kabushiki Kaisha Preventive or therapeutic agents for pancreatic cancer, ovarian cancer, or liver cancer comprising a novel water-solube prodrug
RU2439073C1 (ru) * 2010-07-13 2012-01-10 Государственное образовательное учреждение высшего профессионального образования "Кубанский государственный технологический университет" (ГОУ ВПО "КубГТУ") СПОСОБ ПОЛУЧЕНИЯ ПРОИЗВОДНЫХ ИНДОЛИЗИНО[7,6-b]ИНДОЛА
HUE060364T2 (hu) 2019-03-29 2023-02-28 Medimmune Ltd Vegyületek és konjugátumaik

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4473692A (en) 1981-09-04 1984-09-25 Kabushiki Kaisha Yakult Honsha Camptothecin derivatives and process for preparing same
US4939255A (en) * 1987-06-24 1990-07-03 Daiichi Pharmaceutical Co., Ltd. Hexa-cyclic camptothecin derivatives
HU213136B (en) * 1990-08-14 1997-02-28 Kyorin Seiyaku Kk Process for producing fluoroethyl camptothecin derivatives and pharmaceutical compositions containing them
JP3008226B2 (ja) * 1991-01-16 2000-02-14 第一製薬株式会社 六環性化合物
JP3359955B2 (ja) * 1992-07-16 2002-12-24 第一製薬株式会社 抗腫瘍剤
GB9402934D0 (en) * 1994-02-16 1994-04-06 Erba Carlo Spa Camptothecin derivatives and process for their preparation
US5663177A (en) * 1995-05-31 1997-09-02 Smithkline Beecham Corporation Water soluble camptothecin analogs
ATE329903T1 (de) 1997-02-14 2006-07-15 Bionumerik Pharmaceuticals Inc Hochgradig lipophile camptothecin-derivate
GB9715821D0 (en) * 1997-07-25 1997-10-01 Pharmacia & Upjohn Spa Amidino-camptothecin derivatives

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006518374A (ja) * 2003-02-21 2006-08-10 中外製薬株式会社 六環式化合物の調製法

Also Published As

Publication number Publication date
ATE398131T1 (de) 2008-07-15
HUP0500062A3 (en) 2012-12-28
EP1480984B9 (en) 2009-03-11
US7109195B2 (en) 2006-09-19
RS47004A (sr) 2007-02-05
BR0214615A (pt) 2004-09-14
RS51051B (sr) 2010-10-31
US20030144304A1 (en) 2003-07-31
HK1072935A1 (en) 2005-09-16
CN1617874A (zh) 2005-05-18
TW200408642A (en) 2004-06-01
ES2307830T3 (es) 2008-12-01
PA8558901A1 (es) 2003-06-30
DE60227113D1 (de) 2008-07-24
US20050059679A1 (en) 2005-03-17
PE20030725A1 (es) 2003-08-28
US6825194B2 (en) 2004-11-30
TWI258481B (en) 2006-07-21
PL370479A1 (en) 2005-05-30
CA2468824A1 (en) 2003-06-05
MY136138A (en) 2008-08-29
MXPA04005185A (es) 2004-08-11
NZ533568A (en) 2006-01-27
EP1480984A2 (en) 2004-12-01
RU2299212C2 (ru) 2007-05-20
HUP0500062A2 (hu) 2005-04-28
RU2004119841A (ru) 2005-03-27
PL207510B1 (pl) 2010-12-31
UA80409C2 (en) 2007-09-25
WO2003045952A3 (en) 2003-10-16
WO2003045952A2 (en) 2003-06-05
KR20040062976A (ko) 2004-07-09
CA2468824C (en) 2011-01-11
NO20042729L (no) 2004-08-27
AU2002356720B2 (en) 2009-01-29
EP1480984B1 (en) 2008-06-11
IL162058A0 (en) 2005-11-20
GT200200250A (es) 2004-01-15
HK1077303A1 (en) 2006-02-10
CN100338066C (zh) 2007-09-19
JP2005511643A (ja) 2005-04-28
UY27560A1 (es) 2003-05-30
AU2002356720A1 (en) 2003-06-10
KR100895746B1 (ko) 2009-04-30
NO329005B1 (no) 2010-07-19
ZA200404522B (en) 2005-01-04

Similar Documents

Publication Publication Date Title
CN116096372B (zh) 一种egfr抑制剂、其制备方法和在药学上的应用
TWI506026B (zh) 純化之吡咯并喹啉基－吡咯啶－２，５－二酮組成物以及製造與使用彼之方法
US20230416270A1 (en) Novel camptothecin derivative, composition comprising same and use thereof
US20230295163A1 (en) Tetracyclic derivative, method for preparing same and use thereof in medicine
US20090312554A1 (en) Novel Process for the Preparation of Hexacyclic Compounds
TW202304912A (zh) 用作cdk激酶抑制劑的化合物及其應用
JP4305909B2 (ja) 六環式化合物
JP4923067B2 (ja) カンプトテシン誘導体及びその応用
CN115433207A (zh) 作为egfr抑制剂的大环杂环类化合物及其应用
TWI794576B (zh) 一類含氟取代的苯并噻吩類化合物及其藥物組合物及應用
CN112279863A (zh) Hsp90抑制剂与喜树碱衍生物的偶联物及其制备方法与应用
HK1072935B (en) Hexacyclic compounds
HK1072935C (en) Hexacyclic compounds
CN120383584A (zh) 喹唑啉酮衍生物及其制备方法和用途

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050317

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050629

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050629

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090128

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090327

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20090422

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20090424

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120515

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120515

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120515

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130515

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130515

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140515

Year of fee payment: 5

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees